This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawley, J. S.
Right arrow Articles by Jorgensen, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawley, J. S.
Right arrow Articles by Jorgensen, J. H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2008, p. 351-352, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00766-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy{triangledown}

Joshua S. Hawley,1 Clinton K. Murray,1* and James H. Jorgensen2

Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas,1 Department of Pathology, University of Texas Health Science Center, San Antonio, Texas2

Received 14 June 2007/ Returned for modification 22 August 2007/ Accepted 8 October 2007

Colistin heteroresistance has been reported among Acinetobacter isolates; however, its association with prior colistin therapy has not been not described. A population analysis profile identified resistant Acinetobacter subpopulations from colistin-susceptible clinical isolates. The proportion of cells exhibiting heteroresistance was significantly higher among isolates recovered from patients treated with colistin.


* Corresponding author. Mailing address: Infectious Disease Service (MCHE-MDI-7E), Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234. Phone: (210) 916-4355. Fax: (210) 916-0388. E-mail: Clinton.Murray{at}amedd.army.mil

{triangledown} Published ahead of print on 22 October 2007.


Antimicrobial Agents and Chemotherapy, January 2008, p. 351-352, Vol. 52, No. 1
0066-4804/08/$08.00+0     doi:10.1128/AAC.00766-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Suh, J.-Y., Son, J. S., Chung, D. R., Peck, K. R., Ko, K. S., Song, J.-H. (2010). Nonclonal Emergence of Colistin-Resistant Klebsiella pneumoniae Isolates from Blood Samples in South Korea. Antimicrob. Agents Chemother. 54: 560-562 [Abstract] [Full Text]  
  • Soon, R. L., Nation, R. L., Hartley, P. G., Larson, I., Li, J. (2009). Atomic Force Microscopy Investigation of the Morphology and Topography of Colistin-Heteroresistant Acinetobacter baumannii Strains as a Function of Growth Phase and in Response to Colistin Treatment. Antimicrob. Agents Chemother. 53: 4979-4986 [Abstract] [Full Text]  
  • Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., Bonomo, R. A. (2009). Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System. Antimicrob. Agents Chemother. 53: 3628-3634 [Abstract] [Full Text]  
  • Cummins, J., Reen, F. J., Baysse, C., Mooij, M. J., O'Gara, F. (2009). Subinhibitory concentrations of the cationic antimicrobial peptide colistin induce the pseudomonas quinolone signal in Pseudomonas aeruginosa. Microbiology 155: 2826-2837 [Abstract] [Full Text]  
  • Sun, S., Negrea, A., Rhen, M., Andersson, D. I. (2009). Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother. 53: 2298-2305 [Abstract] [Full Text]  
  • Arroyo, L. A., Mateos, I., Gonzalez, V., Aznar, J. (2009). In Vitro Activities of Tigecycline, Minocycline, and Colistin-Tigecycline Combination against Multi- and Pandrug-Resistant Clinical Isolates of Acinetobacter baumannii Group. Antimicrob. Agents Chemother. 53: 1295-1296 [Full Text]